FAYUVI Trademark

Trademark Overview


On Thursday, October 17, 2024, a trademark application was filed for FAYUVI with the United States Patent and Trademark Office. The USPTO has given the FAYUVI trademark a serial number of 98806913. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 6, 2025. This trademark is owned by Ultragenyx Pharmaceutical Inc.. The FAYUVI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical, scientific, and medical research and development in the field of genetic, central nervous system, and lysosomal storage diseases and disorders; scientific research in the nature of conducting clinical trials for others in the field of genetic, central nervous system, and lysosomal storage diseases and disorders; scientific and medical research, namely, compiling and sharing of patient data for research purposes in the field of genetic, central nervous system, and lysosomal storage diseases and disorders; providing medical and scientific research information in the field of genetic, central nervous system, and lysosomal storage diseases and disorders; providing medical research and scientific research information in the field of genetic, central nervous system, and lysosomal storage diseases and disorders; pharmaceutical, scientific, and medical research and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the field...
fayuvi

General Information


Serial Number98806913
Word MarkFAYUVI
Filing DateThursday, October 17, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, May 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 6, 2025

Trademark Statements


Goods and ServicesPharmaceutical, scientific, and medical research and development in the field of genetic, central nervous system, and lysosomal storage diseases and disorders; scientific research in the nature of conducting clinical trials for others in the field of genetic, central nervous system, and lysosomal storage diseases and disorders; scientific and medical research, namely, compiling and sharing of patient data for research purposes in the field of genetic, central nervous system, and lysosomal storage diseases and disorders; providing medical and scientific research information in the field of genetic, central nervous system, and lysosomal storage diseases and disorders; providing medical research and scientific research information in the field of genetic, central nervous system, and lysosomal storage diseases and disorders; pharmaceutical, scientific, and medical research and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the fields of gene therapy, genetic, central nervous system, and lysosomal storage diseases and disorders; biomedical research in the field of gene therapy design and delivery; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; scientific research in the nature of conducting clinical trials for others in the field of gene therapy design and delivery

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 17, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameUltragenyx Pharmaceutical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Party NameUltragenyx Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Trademark Events


Event DateEvent Description
Thursday, October 17, 2024NEW APPLICATION ENTERED
Thursday, October 17, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 24, 2025ASSIGNED TO EXAMINER
Monday, March 31, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 31, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 31, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 25, 2025NON-FINAL ACTION WRITTEN
Tuesday, March 25, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 25, 2025NON-FINAL ACTION E-MAILED
Saturday, April 5, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 30, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 6, 2025PUBLISHED FOR OPPOSITION
Tuesday, May 6, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED